Micro
Emerging
Active
Laughing Water Capital's investment in LRN
New narrative with limited coverage — still forming.
Score
0.2
Velocity
▲ 0.0
Articles
3
Sources
1
Sentiment Timeline
Event Timeline
🤖
AI Overview
Laughing Water Capital's Q1 2026 Performance and Positions
Laughing Water Capital's Class A investment returned -4.5% net of fees in Q1 2026, underperforming the SP500TR. The firm provided updates on its holdings, including NextNav (NN), Stride (LRN), and Lifecore Biomedical (LFCR).
The underperformance was driven by Laughing Water's positions in these companies, which faced headwinds. NextNav's stock was impacted by regulatory delays, while Stride's struggles were attributed to challenges in its education sector. Lifecore Biomedical's stock was affected by supply chain disruptions.
Investors should monitor Stride's earnings, due on May 15, for updates on its educational platform's performance. Additionally, regulatory developments around NextNav's spectrum access and Lifecore's supply chain resilience will be crucial to watch.
Laughing Water Capital's Class A investment returned -4.5% net of fees in Q1 2026, underperforming the SP500TR. The firm provided updates on its holdings, including NextNav (NN), Stride (LRN), and Lifecore Biomedical (LFCR).
The underperformance was driven by Laughing Water's positions in these companies, which faced headwinds. NextNav's stock was impacted by regulatory delays, while Stride's struggles were attributed to challenges in its education sector. Lifecore Biomedical's stock was affected by supply chain disruptions.
Investors should monitor Stride's earnings, due on May 15, for updates on its educational platform's performance. Additionally, regulatory developments around NextNav's spectrum access and Lifecore's supply chain resilience will be crucial to watch.
AI Overview as of Apr 27, 2026
Timeline
Last UpdatedApr 24, 2026